On the pharma side, emerging markets chief Abbas Hussain--who, if you'll recall, last year publicly apologized to China's government and offered price cuts in penance for the company's $489 million doctor bribery scandal--will assume the role of global pharmaceuticals president, and he'll have North American pharma president Dierdre Connelly reporting to him, Rhyne said. And they'll have their work cut out for them: In the third quarter, Glaxo reported pharmaceutical sales down 12% in the U.S., thanks in part to an 18% respiratory plunge. Megablockbuster Advair powered that decline, with increased competition helping take a 25% bite out of the aging behemoth's top-line haul. - read the release (PDF) Special Reports: The 25 most influential people in biopharma today - 2012 - Moncef Slaoui | The top 10 pharma companies by 2013 revenue - GlaxoSmithKline | The 10 best-selling drugs of 2013 - Advair/Seretide